[The analysis of long-term prognostic factors after laparoscopic liver resection for intrahepatic cholangiocarcinoma and establishment of survival Nomogram model].
Zi-Fang Shen(Institute of Plant Protection), Liang Xiao(Tianjin Medical University), Wenlong Zhai(Zhengzhou University), Zhaohui Tang(XinHua Hospital), Tianqiang Song(Tianjin Medical University Cancer Institute and Hospital), C Chen(First Affiliated Hospital of Xi'an Jiaotong University), Zhangjun Cheng(Zhongda Hospital Southeast University), Donge Tang(Shenzhen Second People's Hospital), C D Sun(Qingdao University), Yujun He(University of Colorado Denver), R. Lin(Second Affiliated Hospital of Jilin University), Haorong Wu(Sichuan University), X H Mao(Hunan Provincial People's Hospital), J D Li(GlaxoSmithKline (China)), Zhimin Geng(Children's Hospital of Zhejiang University)
Cited by 0
Related Papers
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
|The Lancet Oncology|2015|1.1k
Exosome biogenesis: machinery, regulation, and therapeutic implications in cancer
|Molecular Cancer|2022|652
DC isoketal-modified proteins activate T cells and promote hypertension
|Journal of Clinical Investigation|2014|533
Immune activation caused by vascular oxidation promotes fibrosis and hypertension
|Journal of Clinical Investigation|2015|231
CD70 Exacerbates Blood Pressure Elevation and Renal Damage in Response to Repeated Hypertensive Stimuli
|Circulation Research|2016|171